|
http://www.aarkstore.com/reports/Diazyme-Laboratories-Product-Pipeline-Analysis-159332.html Summary Diazyme Laboratories (Diazyme) is a medical device company is principally engaged in the development and marketing of disease specific test reagents and clinical chemistry rapid tests for the in-vitro diagnostic markets. The company operates as a division of General Atomics. Diazyme’s products include diagnostic blood tests for liver disease, cardiac markers, diabetes and electrolytes. Diazyme’s patented Substrate-Trapping-Enzyme (STE) Technology employs genetically engineered enzymes that lack catalytic activity but specifically and tightly trap their substrate or product molecules as the basis for clinical diagnostic tests. The company products are used for diagnostic blood tests for liver disease, cardiac markers, diabetes and electrolytes. The company receives FDA clearance for its product SMART HbA1c assay. The operational business of the company includes Europe and the US. Diazyme is headquartered at Poway in California, the US. This report is a source for data, analysis and actionable intelligence on the Diazyme Laboratories portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date. Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Scope - Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments. - Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase. - Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date. - Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application. - Data on relevant clinical trials and product patent details, wherever applicable. - Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility. For more information, please visit: http://www.aarkstore.com/reports/Diazyme-Laboratories-Product-Pipeline-Analysis-159332.html Or email us at contact@aarkstore.com or call +918149852585 Aarkstore Enterprise Tel : +912227453309 Mobile No:+08149852585 Email : contact@aarkstore.com Website : http://www.aarkstore.com Blog: http://www.emarketreports.com Follow us on twitter: http://twitter.com/aarkstoredotcom http://in.linkedin.com/in/aarkstore http://www.facebook.com/aarkstoreenterprise
Related Articles -
Diazyme Laboratories, Product Pipeline Analysis, chemistry rapid tests, clinical chemistry, Substrate-Trapping-Enzyme, diagnostic, blood tests,
|
